Skip to main content

Table 3 The results of GSEA for HELQ and EGR3 with significantly enriched pathways

From: HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia

 

Pathway

Enrichment Score

NES

P value

FDR adjusted p value

Q values

HELQ expression associated pathways

Kras signaling

− 0.435668418

− 2.1532

1.00E−10

5.00E−09

3.05E−09

Hedgehog signaling

− 0.42542167

− 1.6012

0.00905

0.0266321

0.01626

coagulation

− 0.40041732

− 1.9035

1.78E−06

1.78E−05

1.09E−05

Myogenesis

− 0.366088795

− 1.8159

3.62E−06

2.64E−05

1.61E−05

Epithelial mesenchymal transition

− 0.365397776

− 1.8159

3.69E−06

2.64E−05

1.61E−05

Bile acid metabolism

− 0.340839788

− 1.5737

0.00346

0.0123508

0.00754

Estrogen response late

− 0.335392317

− 1.6646

7.44E−05

0.0004131

0.00025

Inflammatory response

− 0.332882791

− 1.6521

0.0001

0.000507

0.00031

Spermatogenesis

− 0.312304664

− 1.4807

0.00614

0.0191922

0.01172

Estrogen response early

− 0.307378963

− 1.5247

0.00124

0.0051754

0.00316

Xenobiotic metabolism

− 0.304376309

− 1.5098

0.00158

0.0060767

0.00371

DNA repair

0.240957608

1.47711

0.00535

0.0178322

0.01089

MYC targets

0.255275512

1.66642

7.34E−05

0.0004131

0.00025

G2M checkpoint

0.301740945

1.98069

1.82E−07

2.28E−06

1.39E−06

E2F targets

0.304239585

1.99709

1.16E−07

1.93E−06

1.18E−06

Mitotic spindle

0.30860828

1.97486

4.61E−08

1.15E−06

7.04E−07

Protein secretion

0.32775742

1.88719

0.00013

0.0005808

0.00035

EGR3 expression associated pathways

Interferon alpha response

− 0.498828541

− 2.3019

7.24E−09

3.62E−07

1.45E−07

Cholesterol homeostasis

− 0.433630867

− 1.8937

8.29E−05

0.0003453

0.00014

Reactive oxigen species pathway

− 0.410797211

− 1.6669

0.00434

0.0120436

0.00482

Coagulation

− 0.381436147

− 1.8811

8.40E−06

5.59E−05

2.24E−05

Myogenesis

− 0.35817246

− 1.8869

3.24E−06

3.24E−05

1.30E−05

Interferon gamma response

− 0.353929759

− 1.8643

1.82E−06

2.27E−05

9.09E−06

IL6-JAK-STAT3 signaling

− 0.345542037

− 1.5649

0.00978

0.0232876

0.00932

Kras signaling

− 0.329603523

− 1.732

8.04E−05

0.0003453

0.00014

epithelial mesenchymal transition

− 0.32757194

− 1.7247

4.34E−05

0.0002168

8.67E−05

Estrogen response late

− 0.321965048

− 1.6931

0.00013

0.0004868

0.00019

Inflammatory response

− 0.306318547

− 1.6109

0.00055

0.0019486

0.00078

Complement

− 0.286012557

− 1.5067

0.00293

0.0086057

0.00344

Apoptosis

− 0.278729142

− 1.4182

0.01129

0.0243914

0.00976

Estrogen response early

− 0.272180964

− 1.4339

0.00861

0.0215358

0.00861

Glycolysis

− 0.268495638

− 1.4144

0.01088

0.0243914

0.00976

Adipogenesis

− 0.26708006

− 1.4058

0.00807

0.0212352

0.00849

Hypoxia

− 0.264798339

− 1.3925

0.01171

0.0243914

0.00976

Allograft rejection

− 0.260668803

− 1.3732

0.01705

0.0340906

0.01364

PI3K-Akt-mTOR signaling

0.312772587

1.4756

0.01953

0.0375598

0.01502

DNA repair

0.326826349

1.62277

0.00084

0.0027889

0.00112

Mitotic spindle

0.339594124

1.78072

3.16E−05

0.0001753

7.01E−05

G2M checkpoint

0.357870462

1.86809

4.20E−06

3.50E−05

1.40E−05

E2F targets

0.399460879

2.08519

2.71E−08

4.51E−07

1.80E−07

MYC targets v1

0.401746954

2.09159

1.97E−08

4.51E−07

1.80E−07

MYC targets v2

0.428081704

1.80452

0.00173

0.0054071

0.00216

Protein secretion

0.440075051

2.06176

8.94E−06

5.59E−05

2.24E−05